Advances in the treatment of malignant tumors with neurological drugs
Authors:
Open Access
- 16 July 2025
- journal article
- review article
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-22
Abstract
The nervous system governs the body’s components and is essential for the physiological functions of all organ systems. The nervous system governs how the body senses, processes, and responds to its environment. Through a complex network of neurons and supporting cells, it connects sensory organs with the brain and spinal cord, and coordinates communication with target organs and tissues throughout the body. This integration of sensory, motor, autonomic, and endocrine functions makes the nervous system essential for maintaining homeostasis and systemic coordination.Consequently, it is anticipated that the nervous system exerts parallel regulatory influences on cancer. Over the past decade, studies have demonstrated a reciprocal relationship between the nervous system and cancer. Taking gliomas, prostate cancer, and breast cancer as examples, where specific nerve types (parasympathetic, sympathetic, or sensory) directly or indirectly control the initiation, progression, and metastasis of cancer. Similarly, cancer can reshape and hijack the structure and function of the nervous system. Chemotherapy has traditionally been the primary and most effective antitumor treatment, while the discovery of neuro-tumor interactions unveils novel strategies for repurposing neuroactive agents as adjuncts to this conventional therapeutic approach. This review elucidates cancer neuroscience through the examples of gliomas, prostate cancer, and breast cancer. Structured around key neuropharmacological receptors, the review systematically explores the potential applications of neuroactive agents and their targets across a broad spectrum of cancer therapies.Keywords
Funding Information
- Yongxiang Zhao (No. AA24263028, No. AA24263028, No. AA24263028, No. AA24263028)
This publication has 96 references indexed in Scilit:
- Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinomaCancer Communications, 2020
- Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2–/– mice and human cholangiocarcinoma tumorigenesis: [RETRACTED]Hepatology, 2018
- Retracted: Norepinephrine induces VEGF expression and angiogenesis by a hypoxia‐inducible factor‐1α protein‐dependent mechanismInternational Journal of Cancer, 2010
- Nicotinic receptor‐associated modulation of stimulatory and inhibitory neurotransmitters in NNK‐induced adenocarcinoma of the lungs and pancreasThe Journal of Pathology, 2009
- Reduced tumor growth in a mouse model of schizophrenia, lacking the dopamine transporterInternational Journal of Cancer, 2008
- Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cellsBreast Cancer Research and Treatment, 2006
- The norepinephrine‐driven metastasis development of PC‐3 human prostate cancer cells in BALB/c nude mice is inhibited by β‐blockersInternational Journal of Cancer, 2006
- In vitro dorsal root ganglia and human prostate cell line interaction: Redefining perineural invasion in prostate cancerThe Prostate, 2001
- Histamine in brain development and tumorsSeminars in Cancer Biology, 2000
- Inhibition and Inhibition Kinetics of Angiotensin Converting Enzyme Activity by Hemorphins, Isolated from a Peptic Bovine Hemoglobin HydrolysateBiochemical and Biophysical Research Communications, 1994